Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now displays release v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedA site-wide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check45 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check66 days agoChange DetectedA new Revision: v3.7.0 entry was added to the version history. The previous Revision: v3.6.6 entry was removed from the list.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now shows a new site revision, updating from v3.6.5 to v3.6.6, indicating a recent UI/software update of the page.SummaryDifference0.1%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.